Latest New Drug Application Stories
DUBLIN, Feb. 24, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S.
RALEIGH, N.C., Feb. 23, 2015 /PRNewswire/ -- BioDelivery Sciences International, Inc.
CHENGDU, China, Feb. 17, 2015 /PRNewswire/ -- Tianyin Pharmaceutical Inc.
- Decision could speed access to LCZ696 for heart failure with reduced ejection fraction patients in the US, reducing total review time from 12 to 8 months(1) EAST HANOVER, N.J., Feb.
HAYWARD, Calif., Jan. 26, 2015 /PRNewswire/ -- Impax Laboratories, Inc. (NASDAQ: IPXL) announced today that the U.S.
EWING, N.J., Jan. 20, 2015 /PRNewswire/ -- Celator Pharmaceuticals, Inc.
IGI Filed Eleven ANDAs in 2014, and IGI Now Has Twenty-Two Applications Pending at the FDA BUENA, N.J., Dec. 23, 2014 /PRNewswire/ -- IGI Laboratories, Inc.
Biohaven filed a pre-IND meeting request with the FDA regarding lead investigational agent BHV-0223, receives written response in lieu of an in-person meeting TORONTO, Dec.
Expects to complete submission in the first half of 2015 DUBLIN, Dec.
IGI Now Has Nineteen Applications Pending at the FDA BUENA, N.J., Dec. 1, 2014 /PRNewswire/ -- IGI Laboratories, Inc.
- In medieval musical notation, a sign or neume denoting a shake or trill.